Three medicines used to treat children who have severe asthma attacks will be compared in a national trial.
Asthma is the most common long-term condition among children and young people.
EVITA will shed light on which of the three treatments: aminophylline, magnesium sulfate or salbutamol, is most effective. This will help to inform clinical guidelines in the future.
The EVITA trial has been awarded over £2.3 million from the National Institute for Health and Care Research (NIHR). Southampton’s Professor Graham Roberts and Dr Katrina Cathie will lead the trial, together with Professor Damian Roland in Leicester.
More information can be found at: www.evita.org.uk